Avanos Medical (AVNS) Stock Gains 17% This Month: How Does it Score?

 

Avanos Medical (AVNS) stock is up more than 17% over the past 30 days. AVNS stock is down -38.40% over the last 12 months, and the average rating from Wall Street analysts is a Moderate Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives AVNS stock a score of 38 out of a possible 100.

That score is chiefly influenced by a fundamental score of 18. In addition to the average rating from Wall Street analysts, AVNS stock has a mean target price of $47.83. This means analysts expect the stock to gain 22.77% over the next 12 months. AVNS’s score also includes a long-term technical score of 45. The short-term technical score for AVNS is 50.

Click Here to get the full Stock Score Report on Avanos Medical Inc (AVNS).

What’s Happening with AVNS Stock Today

Avanos Medical Inc (AVNS) stock is higher by 6.07% while the S&P 500 is higher by 1.25% as of 3:50 PM on Wednesday, Oct 9. AVNS is higher by $2.23 from the previous closing price of $36.73 on volume of 789,775 shares. Over the past year the S&P 500 has risen 1.55% while AVNS is down -38.40%. AVNS lost -$0.26 per share in the over the last 12 months.

Symbols: AVNS

You May Also Like